SEC Filings | Zentalis Pharmaceuticals

Filing Date	Form	Description	View
Apr 02, 2020	8-A12B	Registration of certain classes of securities 12(b) of the Securities Exchange Act	0001193125-20-096074.pdf 0001193125-20-096074.rtf 0001193125-20-096074.xls View HTML
Apr 02, 2020	S-1MEF	Registration of up to an additional 20% of securities for any offering registered on an S-1	0001193125-20-096862.pdf 0001193125-20-096862.rtf View HTML
Apr 02, 2020	EFFECT	EFFECT	9999999995-20-000670.xls View HTML
Mar 31, 2020	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-20-091784.pdf 0001193125-20-091784.rtf 0001193125-20-091784.xls View HTML
Mar 31, 2020	CORRESP	CORRESP	0001193125-20-092892.pdf 0001193125-20-092892.rtf 0001193125-20-092892.xls View HTML
Mar 31, 2020	CORRESP	CORRESP	0001193125-20-092900.pdf 0001193125-20-092900.rtf 0001193125-20-092900.xls View HTML
Mar 30, 2020	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-20-089742.pdf 0001193125-20-089742.rtf 0001193125-20-089742.xls View HTML
Mar 13, 2020	CORRESP	CORRESP	0001193125-20-072939.pdf 0001193125-20-072939.rtf 0001193125-20-072939.xls View HTML
Mar 13, 2020	CORRESP	CORRESP	0001193125-20-073100.pdf 0001193125-20-073100.rtf 0001193125-20-073100.xls View HTML
Mar 11, 2020	UPLOAD	UPLOAD	0000000000-20-002196.pdf 0000000000-20-002196.rtf View HTML

Data provided by Kaleidoscope.